Abstract
Introduction
Driven primarily by continued uptake of Shire' s market leading ADHD drug,
Adderall XR (amphetamine extended release), seven major market ADHD revenues
grew strongly at a compound annual growth rate (200408) of 13.5% to reach
almost $4.4 billion in 2008. Ongoing uptake of Shire' s Vyvanse
(lisdexamfetamine), was also a key contributor to market growth between 2007
and 2008.
Scope of this research
- This report gives a strategic analysis of the likely impact that recent
events will have on the future ADHD market.
- Includes sales forecasts for the key ADHD brands and generics as well as
pipeline agents in the seven major markets to 2018.
- Provides a global market snapshot by including sales analysis for leading
ADHD brands outside the seven major markets.
- Key conclusions are supported by key opinion leader comment.
Research and analysis highlights
The April 2009 launch of generic competition in the US will cause sales of
Shire' s leading ADHD product, Adderall XR, to decline sharply. However,
Datamonitor maintains the expectation that Shire will remain the dominant
player in the ADHD market over the forecast period due to the company' s broad
portfolio of products.
Intuniv (guanfacine hydrochloride) represents Shire' s first venture into the
non-stimulant segment of the ADHD market. Datamonitor believes Shire will
market Intuniv as a second-line treatment option, due to clinical data
demonstrating inferior efficacy to stimulant treatments, putting it in direct
competition with Strattera.
The publication of a US government-sponsored study reporting an association
between ADHD treatments and sudden unexplained death among pediatrics will
reignite the debate over the safety of ADHD drugs in children. The media
coverage will cause some parents in the US to choose to discontinue or not
begin stimulant therapy for their children.
Key reasons to purchase this research
- Understand when late-stage pipeline products will launch and what impact
these will have on the market during the forecast period 2009 to 2018.
- Quantify the current size of the seven major markets and the trends in the
rest of the world.
- Assess the impact of events, such as patent expiries and new product
launches, on the future sales of key brand name ADHD products.
| 
View Cart
